# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-21-008372
Filing Date
2021-02-25
Accepted
2021-02-24 21:54:55
Documents
84
Period of Report
2020-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | acad-10k_20201231.htm iXBRL | 10-K | 3738457
2 | EX-3.2 | acad-ex32_633.htm | EX-3.2 | 6902
3 | EX-10.11 | acad-ex1011_411.htm | EX-10.11 | 38630
4 | EX-21.1 | acad-ex211_12.htm | EX-21.1 | 5023
5 | EX-23.1 | acad-ex231_7.htm | EX-23.1 | 12588
6 | EX-31.1 | acad-ex311_11.htm | EX-31.1 | 10354
7 | EX-31.2 | acad-ex312_8.htm | EX-31.2 | 10398
8 | EX-32.1 | acad-ex321_10.htm | EX-32.1 | 5658
9 | EX-32.2 | acad-ex322_9.htm | EX-32.2 | 6405
10 | GRAPHIC | gpmwmhg00msf000001.jpg | GRAPHIC | 196247
11 | GRAPHIC | gpmwmhg00msf000002.jpg | GRAPHIC | 150782
| Complete submission text file | 0001564590-21-008372.txt |  | 13998063

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
12 | XBRL TAXONOMY EXTENSION SCHEMA | acad-20201231.xsd | EX-101.SCH | 66754
13 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | acad-20201231_cal.xml | EX-101.CAL | 74858
14 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | acad-20201231_def.xml | EX-101.DEF | 197645
15 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | acad-20201231_lab.xml | EX-101.LAB | 563946
16 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | acad-20201231_pre.xml | EX-101.PRE | 414386
17 | EXTRACTED XBRL INSTANCE DOCUMENT | acad-10k_20201231_htm.xml | XML | 2861467

Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

EIN.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50768 | Film No.: 21676204
SIC: 2834 Pharmaceutical Preparations